Innospec Inc.
Bear Case (25th pct.)
-41.0% vs price
Base Case (Median)
-19.7% vs price
Bull Case (75th pct.)
-12.9% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $5.95 | -93.7% | High (40%) |
| PE Comparable | $86.80 | -7.5% | Medium (25%) |
| Growth Trajectory DCF | $131.56 | 40.2% | Medium (20%) |
| Graham Number | $76.66 | -18.3% | Medium (30%) |
| EV/EBITDA | $75.32 | -19.7% | Medium (20%) |
| EV/FCF | $52.17 | -44.4% | Medium (20%) |
| Earnings Power Value | $58.56 | -37.6% | Medium (50%) |
Based on 7 out of 8 methods, IOSP appears overvalued at the current price of $93.83. The base case fair value of $75.32 implies 19.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.